147 related articles for article (PubMed ID: 24287622)
1. Nano-encapsulation of plitidepsin: in vivo pharmacokinetics, biodistribution, and efficacy in a renal xenograft tumor model.
Oliveira H; Thevenot J; Garanger E; Ibarboure E; Calvo P; Aviles P; Guillen MJ; Lecommandoux S
Pharm Res; 2014 Apr; 31(4):983-91. PubMed ID: 24287622
[TBL] [Abstract][Full Text] [Related]
2. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative.
Lollo G; Hervella P; Calvo P; Avilés P; Guillén MJ; Garcia-Fuentes M; Alonso MJ; Torres D
Int J Pharm; 2015 Apr; 483(1-2):212-9. PubMed ID: 25681727
[TBL] [Abstract][Full Text] [Related]
3. Cellular Uptake and Cytotoxic Effect of Epidermal Growth Factor Receptor Targeted and Plitidepsin Loaded Co-Polymeric Polymersomes on Colorectal Cancer Cell Lines.
Goñi-de-Cerio F; Thevenot J; Oliveira H; Pérez-Andrés E; Berra E; Masa M; Suárez-Merino B; Lecommandoux S; Heredia P
J Biomed Nanotechnol; 2015 Nov; 11(11):2034-49. PubMed ID: 26554161
[TBL] [Abstract][Full Text] [Related]
4. Improved pharmacokinetic profile of lipophilic anti-cancer drugs using ανβ3-targeted polyurethane-polyurea nanoparticles.
Rocas P; Fernández Y; García-Aranda N; Foradada L; Calvo P; Avilés P; Guillén MJ; Schwartz S; Rocas J; Albericio F; Abasolo I
Nanomedicine; 2018 Feb; 14(2):257-267. PubMed ID: 29127040
[TBL] [Abstract][Full Text] [Related]
5. A new potential nano-oncological therapy based on polyamino acid nanocapsules.
Gonzalo T; Lollo G; Garcia-Fuentes M; Torres D; Correa J; Riguera R; Fernandez-Megia E; Calvo P; Avilés P; Guillén MJ; Alonso MJ
J Control Release; 2013 Jul; 169(1-2):10-6. PubMed ID: 23591661
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics meta-analysis of plitidepsin (Aplidin) in cancer subjects.
Nalda-Molina R; Valenzuela B; Ramon-Lopez A; Miguel-Lillo B; Soto-Matos A; Perez-Ruixo JJ
Cancer Chemother Pharmacol; 2009 Jun; 64(1):97-108. PubMed ID: 18941750
[TBL] [Abstract][Full Text] [Related]
7. A polymeric nanoparticle consisting of mPEG-PLA-Toco and PLMA-COONa as a drug carrier: improvements in cellular uptake and biodistribution.
Yi Y; Kim JH; Kang HW; Oh HS; Kim SW; Seo MH
Pharm Res; 2005 Feb; 22(2):200-8. PubMed ID: 15783067
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E
J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009
[TBL] [Abstract][Full Text] [Related]
9. c-Jun N-terminal kinase phosphorylation is a biomarker of plitidepsin activity.
Muñoz-Alonso MJ; Álvarez E; Guillén-Navarro MJ; Pollán M; Avilés P; Galmarini CM; Muñoz A
Mar Drugs; 2013 May; 11(5):1677-92. PubMed ID: 23697951
[TBL] [Abstract][Full Text] [Related]
10. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel.
Lollo G; Rivera-Rodriguez GR; Bejaud J; Montier T; Passirani C; Benoit JP; García-Fuentes M; Alonso MJ; Torres D
Eur J Pharm Biopharm; 2014 May; 87(1):47-54. PubMed ID: 24530693
[TBL] [Abstract][Full Text] [Related]
11. Phase II clinical and pharmacokinetic study of plitidepsin 3-hour infusion every two weeks alone or with dexamethasone in relapsed and refractory multiple myeloma.
Mateos MV; Cibeira MT; Richardson PG; Prosper F; Oriol A; de la Rubia J; Lahuerta JJ; García-Sanz R; Extremera S; Szyldergemajn S; Corrado C; Singer H; Mitsiades CS; Anderson KC; Bladé J; San Miguel J
Clin Cancer Res; 2010 Jun; 16(12):3260-9. PubMed ID: 20530693
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and Tissue Distribution of Folate-Decorated Human Serum Albumin Loaded With Nano-Hydroxycamptothecin for Tumor Targeting.
Wang W; Liang H; Sun B; Xu J; Zeng Z; Zhao X; Li Q
J Pharm Sci; 2016 Jun; 105(6):1874-1880. PubMed ID: 27129905
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and excretion of
van Andel L; Fudio S; Rosing H; Munt S; Miguel-Lillo B; González I; Tibben MM; de Vries N; de Vries Schultink AHM; Schellens JHM; Beijnen JH
Invest New Drugs; 2017 Oct; 35(5):589-598. PubMed ID: 28111728
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.
Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W
Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802
[TBL] [Abstract][Full Text] [Related]
15. Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumors.
Aspeslagh S; Awada A; S Matos-Pita A; Aftimos P; Bahleda R; Varga A; Soria JC
Anticancer Drugs; 2016 Nov; 27(10):1021-7. PubMed ID: 27610894
[TBL] [Abstract][Full Text] [Related]
16. In vivo anticancer activity of methotrexate-loaded layered double hydroxide nanoparticles.
Choi SJ; Oh JM; Chung HE; Hong SH; Kim IH; Choy JH
Curr Pharm Des; 2013; 19(41):7196-202. PubMed ID: 23489199
[TBL] [Abstract][Full Text] [Related]
17. A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: an Innovative Therapies for Children with Cancer (ITCC) study.
Geoerger B; Estlin EJ; Aerts I; Kearns P; Gibson B; Corradini N; Doz F; Lardelli P; Miguel BD; Soto A; Prados R; Vassal G
Eur J Cancer; 2012 Feb; 48(3):289-96. PubMed ID: 22119199
[TBL] [Abstract][Full Text] [Related]
18. Phase I clinical and pharmacokinetic study of plitidepsin as a 1-hour weekly intravenous infusion in patients with advanced solid tumors.
Izquierdo MA; Bowman A; García M; Jodrell D; Martinez M; Pardo B; Gómez J; López-Martin JA; Jimeno J; Germá JR; Smyth JF
Clin Cancer Res; 2008 May; 14(10):3105-12. PubMed ID: 18483378
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles.
Li S; Wang A; Jiang W; Guan Z
BMC Cancer; 2008 Apr; 8():103. PubMed ID: 18412945
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, tissue distribution and anti-tumour efficacy of paclitaxel delivered by polyvinylpyrrolidone solid dispersion.
Liu X; Sun J; Chen X; Wang S; Scott H; Zhang X; Zhang Q
J Pharm Pharmacol; 2012 Jun; 64(6):775-82. PubMed ID: 22571255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
